Back to search

Article

Low-Risk and Sweet-Spot Second-Generation Antipsychotics Identified Through Receptor Pharmacology and Cardiometabolic TWAS

2026-08-13

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Metabolic adverse effects remain a major limitation of second-generation antipsychotic prescribing. Weight gain, dyslipidemia, hypertension, and type 2 diabetes can affect long-term adherence and may also contribute indirectly to kidney disease risk. Zhou et al. (2024) recently showed that kidney stones and chronic kidney disease share strong cardiometabolic c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c795eca8-fa6c-598f-adbc-998b60ed3ec7
DOI
10.21203/rs.3.rs-10205419/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low-Risk and Sweet-Spot Second-Generation Antipsychotics Identified Through Receptor Pharmacology and Cardiometabolic TWASDOI 10.21203/rs.3.rs-10205419/v1
Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medicationsSemantic proximity
Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medicationsSemantic proximity
Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity
Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity
Pharmaceutical Repurposing Strategies for Metabolic Disorders: Insights from Mendelian Randomization StudiesSemantic proximity
Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity
Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us.Semantic proximity
Genetic Epidemiological Pipeline Identifies Candidate Markers of Clozapine-Induced Metabolic Dysfunction Revealing Potential Avenues for Precision Clozapine PrescriptionSemantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
CPT2-Linked Fatty Acid Oxidation and Autophagy Nodes Connect NMN-Responsive Transcriptional Programs to Schizophrenia BiologySemantic proximity
SPLIT: Safety Prioritization for Long COVID Drug Repurposing via a Causal Integrated Targeting FrameworkSemantic proximity
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database.Semantic proximity
Select a neighboring publication to make it the new centre.